FIELD: chemistry.
SUBSTANCE: invention relates to a cationic lipid which can be used to deliver nucleic acid into the cytoplasm. According to the present invention, the cationic lipid is a compound of formula (1a), or a pharmaceutically acceptable salt thereof, where in formula (1a) L1 and L2 independently represent alkylene group containing from 3 to 10 carbon atoms; R1 and R2 independently represent an alkyl group containing from 4 to 22 carbon atoms, or an alkenyl group having from 4 to 22 carbon atoms; X1 is a single bond or -CO-O-; and ring P is represented by any of formulas (P-1), (P-2), (P-4) and (P-5), where R3 is an alkyl group containing 1 to 3 carbon atoms.
EFFECT: cationic lipid is proposed.
15 cl, 20 tbl, 64 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
CATIONIC LIPID | 2019 |
|
RU2784335C2 |
COMPOUNDS AND COMPOSITIONS FOR SUPPRESSING SHP2 ACTIVITY | 2017 |
|
RU2744988C2 |
PYRANODIPYRIDINE COMPOUND | 2016 |
|
RU2743998C2 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
LIPID COMPOUND AND COMPOSITION BASED THEREON | 2021 |
|
RU2825571C1 |
SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2629118C2 |
C-FMC KINASE INHIBITORS | 2007 |
|
RU2475483C2 |
PIPERIDINE DERIVATIVE | 2008 |
|
RU2475485C2 |
COMPOUNDS | 2016 |
|
RU2725616C2 |
NUCLEIC ACID DERIVATIVE EXHIBITING IMMUNOSTIMULATING ACTIVITY | 2016 |
|
RU2730871C1 |
Authors
Dates
2021-01-21—Published
2017-06-22—Filed